# Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

> **NCT04818099** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 208 (estimated)

## Conditions studied

- Radiation Injuries

## Interventions

- **DRUG:** Vortioxetine 10 mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04818099
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-10
- **Primary completion:** 2023-10-10
- **Final completion:** 2024-04-01
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2021-03-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818099, "Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04818099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*